New Ardena Lab To Boost Bioanalytical Services

Ardena, a contract development and manufacturing organisation with GMP facilities in Belgium, Spain, the Netherlands, and Sweden, has unveiled an extensive expansion in the Netherlands unit's bioanalytical services portfolio unit. This will include opening up a fresh bioanalytical lab at the Pivot Park location in Oss and strengthening bioanalytical offerings at the Assen Centre of Excellence. 

A new, over 3,000 sq. ft. lab at Oss will be fully operational from Q1, 2025 and provide services in terms of advanced analysis for the small as well as larger molecules, including LC-MS/MS as well as fluorometric assays and in addition to the Gyrolab ELISA automation.

“This expansion allows us to quickly scale our operations, leverage an additional pool of talented professionals, and bring enhanced efficiency and value to our clients, from discovery to late-stage clinical phases. Together, these investments demonstrate Ardena’s focus on growth and innovation, reinforcing our strategy to assist clients to navigate through an ever-increasing complex drug development process and bring life-changing therapies to patients worldwide faster,” said Jeremie Trochu, Chief Executive Officer of Ardena.

Meanwhile, the competencies in the immunochemistry and flow cytometry sectors would grow at Ardena's Assen facility along with qPCR capability to encompass additional LC-MS/MS capability and new Hamilton automation. All these are performed following rising client demand for deep and advanced bioanalytical solutions.

Ardena will attain greater flexibility in project timelines and faster turnaround times in meeting the needs of a broad client base-from small biotech startups to large pharma companies, adding the Oss lab to its operations. The enhanced bioanalytical services will include all stages of drug development, providing a wide range of therapeutic modalities-from small molecules and peptides to mRNA, antibodies, antibody-drug conjugates, nanoparticles, and cell and gene therapies.